Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.665 USD | +1.81% | -5.44% | +114.71% |
Financials (USD)
Sales 2024 * | 148M | Sales 2025 * | 178M | Capitalization | 542M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | 1M | EV / Sales 2024 * | 3.67 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.05 x |
P/E ratio 2024 * |
-40
x | P/E ratio 2025 * |
540
x | Employees | 126 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.31% |
Latest transcript on Heron Therapeutics, Inc.
1 day | -0.83% | ||
1 week | -2.70% | ||
Current month | -2.70% | ||
1 month | +22.45% | ||
3 months | +38.46% | ||
6 months | +141.61% | ||
Current year | +111.76% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 23-06-15 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 18-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 21-09-19 |
Craig Johnson
BRD | Director/Board Member | 62 | 14-01-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 3.65 | +1.39% | 825 900 |
24-06-07 | 3.6 | -0.83% | 933,137 |
24-06-06 | 3.63 | -4.97% | 1,351,149 |
24-06-05 | 3.82 | +6.11% | 1,481,058 |
24-06-04 | 3.6 | -6.74% | 2,127,791 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+111.76% | 542M | |
+51.85% | 57.87B | |
+41.65% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- HRTX Stock